Epeius Pharma Israeli Company

Epeius Pharma is a cell and gene therapy company developing biological vehicles for the delivery of therapeutic proteins into the central nervous system. Epeius Pharma's platform could allow for an effective and scalable strategy for disease medication in neurodevelopmental and neurological pathologies that could benefit from direct neuron protein replacement treatments. Its first target indication will be Rett syndrome.